X-150671507-A-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_000252.3(MTM1):​c.1724A>G​(p.Gln575Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,208,938 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q575H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000011 ( 0 hom. 4 hem. )

Consequence

MTM1
NM_000252.3 missense

Scores

3
4
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 8.22

Publications

0 publications found
Variant links:
Genes affected
MTM1 (HGNC:7448): (myotubularin 1) This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy. [provided by RefSeq, Jul 2008]
MTM1 Gene-Disease associations (from GenCC):
  • X-linked myotubular myopathy
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.35289115).
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000252.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTM1
NM_000252.3
MANE Select
c.1724A>Gp.Gln575Arg
missense
Exon 15 of 15NP_000243.1
MTM1
NM_001376908.1
c.1724A>Gp.Gln575Arg
missense
Exon 15 of 15NP_001363837.1
MTM1
NM_001376906.1
c.1721A>Gp.Gln574Arg
missense
Exon 15 of 15NP_001363835.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTM1
ENST00000370396.7
TSL:1 MANE Select
c.1724A>Gp.Gln575Arg
missense
Exon 15 of 15ENSP00000359423.3
MTM1
ENST00000689314.1
c.1769A>Gp.Gln590Arg
missense
Exon 16 of 16ENSP00000510607.1
MTM1
ENST00000685944.1
c.1724A>Gp.Gln575Arg
missense
Exon 15 of 15ENSP00000509266.1

Frequencies

GnomAD3 genomes
AF:
0.0000180
AC:
2
AN:
110870
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000109
AC:
12
AN:
1098068
Hom.:
0
Cov.:
30
AF XY:
0.0000110
AC XY:
4
AN XY:
363432
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26397
American (AMR)
AF:
0.00
AC:
0
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54145
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40478
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000119
AC:
10
AN:
842023
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000180
AC:
2
AN:
110870
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33060
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30431
American (AMR)
AF:
0.00
AC:
0
AN:
10349
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2637
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3543
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2615
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5844
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.0000377
AC:
2
AN:
53047
Other (OTH)
AF:
0.00
AC:
0
AN:
1482
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Severe X-linked myotubular myopathy Uncertain:2
May 20, 2021
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aug 30, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine with arginine at codon 575 of the MTM1 protein (p.Gln575Arg). The glutamine residue is moderately conserved and there is a small physicochemical difference between glutamine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with MTM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 530853). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Inborn genetic diseases Uncertain:1
Dec 14, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1724A>G (p.Q575R) alteration is located in exon 15 (coding exon 14) of the MTM1 gene. This alteration results from a A to G substitution at nucleotide position 1724, causing the glutamine (Q) at amino acid position 575 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

not provided Uncertain:1
Apr 10, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Uncertain
0.070
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.35
T
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.74
T
M_CAP
Pathogenic
0.61
D
MetaRNN
Benign
0.35
T
MetaSVM
Uncertain
0.40
D
MutationAssessor
Benign
1.9
L
PhyloP100
8.2
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.41
Sift
Benign
0.32
T
Sift4G
Benign
0.27
T
Polyphen
0.0050
B
Vest4
0.33
MVP
0.99
MPC
0.87
ClinPred
0.87
D
GERP RS
4.8
Varity_R
0.47
gMVP
0.70
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1347335331; hg19: chrX-149839980; API